BioHarvest Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNVCF research report →
Price Chart
About the company
BioHarvest Sciences Inc. , along with its subsidiaries, supplies a range of nutraceutical products and medical cannabis to customers both in Israel and globally. The company leverages an innovative plant cell growth technology that allows it to cultivate active secondary metabolites directly from cells, completely circumventing the need to grow the actual plant.
- CEO
- Ilan Sobel
- IPO
- 2021
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on CNVCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $109.16M
- P/E
- -6.98
- PEG
- 0.36
- P/S
- 3.84
- P/B
- 68.00
- EV/EBITDA
- -15.64
- Div Yield
- 0.00%
- Gross Margin
- 55.35%
- Op Margin
- -27.75%
- Net Margin
- -51.27%
- ROE
- 190.98%
- ROIC
- -45.32%
Latest fiscal year · YoY change
- Revenue
- $12.67M+130.5%
- Gross Profit
- $5.63M+362.1%
- Op Income
- $-9,966,000
- Net Income
- $-12,564,000-11.8%
- EPS
- $-0.93-8.1%
- OCF Growth
- +7.8%
- FCF Growth
- +4.8%
- 52W High
- $6.30
- 52W Low
- $6.30
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.49
- RSI (14)
- 56
- Avg Volume
- 0
No earnings-call transcripts are available for CNVCF yet.
- Free Float
- 72.5%
- Shares Outstanding
- 17.33M
- Float Shares
- 12.57M
Our CNVCF coverage
Recent articles, reports, and earnings notes.
No research on CNVCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNVCF report →BioHarvest Sciences achieves revenue gains and margin expansion, narrows losses in 2025
proactiveinvestors.com · Mar 31
BioHarvest Sciences advances sustainable fragrance production with rare plant breakthrough
proactiveinvestors.com · Mar 31
BioHarvest Sciences' VINIA gains traction with top spot in US nutraceutical category
proactiveinvestors.com · Mar 26
BioHarvest appoints former Israeli health chief Hezi Levy to board
proactiveinvestors.com · Mar 5
BioHarvest Sciences CEO reflects on milestone year in shareholder letter
proactiveinvestors.com · Jan 7
BioHarvest gets $1.6M Israeli grant to advance botanical synthesis technology
proactiveinvestors.com · Dec 18
BioHarvest Sciences launches VINIA Blood Flow Hydration product in US market
proactiveinvestors.com · Dec 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.